Perhaps Wheeler is too busy with his other interests
He was supposed to have a great relationship with the FDA. He bailed them out on the contamination issue. What has he gotten for MNTA. FDA allowed another generic to use a "patented" process for approval. The "iron-clad" patent was worthless. Shares will slide until there is some news. See you in 2014.